The heparin market share is forecast to reach USD 3,009.44 million, after growing at a CAGR of 6.94% during 2023-2027. The increasing prevalence of blood clotting disorders is analyzed to boost the addictions therapeutics market growth. Moreover, advent of biosimilar low-molecular-weight heparin is the major trend enhancing the overall market demand for heparin during the forecast period.
Get a snapshot on the heparin market analysis: Unlock the Sample Report
Technavio’s report on: “Heparin Market by Product, Route of Administration, and Geography - Forecast and Analysis 2023-2027" covers an in-depth analysis of the following segments of the market.
Product:
Low-molecular-weight heparin: The heparin market growth by the low-molecular-weight heparin segment will be significant during the forecast period. Owing to the wide availability of low-molecular-weight heparin products and their advantages and efficacy, their adoption is expected to grow during the forecast period.
Others
Geography:
Europe: 39% of market growth will develop from Europe during the forecast period. This increasing prevalence of deep vein thrombosis and pulmonary embolism has fueled the adoption of heparin in the region.
North America
Asia
Rest of World (ROW)
The heparin market size will witness a YOY Growth Rate of 6.41% in 2023.
The side effects of heparin will be a major challenge for the heparin market during the forecast period.
Major key heparin market players include: Aspen Pharmacare Holdings, B. Braun SE, Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hebei Changshan Biochemical, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos Rovi, LEO Pharma AS, Nanjing Kingfriend Biochemical, Nichi Iko Pharmaceutical Co. Ltd., Novartis AG, Opocrin SpA, and Sanofi SA.
The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the Europe, North America, Asia, and Rest of World (ROW.
Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2023-2027.
CAGR of the heparin market forecast during 2023-2027.
Market-level data on units, average selling prices, and values of the heparin market share.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the heparin market.
Heparin industry growth across Europe, North America, Asia, and Rest of World (ROW).
